DE60135764D1 - Stickstoffhaltige, fünfgliedrige ringverbindungen - Google Patents

Stickstoffhaltige, fünfgliedrige ringverbindungen

Info

Publication number: DE60135764D1
Authority: DE; Germany
Prior art keywords: alk; con; nitrogenic; group; ring compounds
Prior art date: 2000-10-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE60135764T

Other languages

English (en)

Inventor

Kosuke Yasuda

Hiroshi Morimoto

Saburo Kawanami

Masataka Hikota

Takeshi Matsumoto

Kenji Arakawa

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Mitsubishi Tanabe Pharma Corp

Original Assignee

Mitsubishi Tanabe Pharma Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-06

Filing date

2001-10-05

Publication date

2008-10-23

2001-10-05 Application filed by Mitsubishi Tanabe Pharma Corp filed Critical Mitsubishi Tanabe Pharma Corp

2008-10-23 Application granted granted Critical

2008-10-23 Publication of DE60135764D1 publication Critical patent/DE60135764D1/de

2021-10-06 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/416—2,5-Pyrrolidine-diones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Obesity (AREA)
Endocrinology (AREA)
Hematology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Hydrogenated Pyridines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Peptides Or Proteins (AREA)
Investigating Or Analysing Biological Materials (AREA)
Glass Compositions (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

DE60135764T 2000-10-06 2001-10-05 Stickstoffhaltige, fünfgliedrige ringverbindungen Expired - Lifetime DE60135764D1 (de)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
JP2000308528		2000-10-06
JP2000312562		2000-10-12
JP2001099251		2001-03-30
PCT/JP2001/008802 WO2002030890A1 (fr)	2000-10-06	2001-10-05	Composes azotes a noyau a cinq elements

Publications (1)

Publication Number	Publication Date
DE60135764D1 true DE60135764D1 (de)	2008-10-23

Family

ID=27344889

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DE60135764T Expired - Lifetime DE60135764D1 (de)	2000-10-06	2001-10-05	Stickstoffhaltige, fünfgliedrige ringverbindungen
DE60135862T Expired - Lifetime DE60135862D1 (de)	2000-10-06	2001-10-05	Aliphatische stickstoffhaltige fünfgliedrige ringverbindungen

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DE60135862T Expired - Lifetime DE60135862D1 (de)	2000-10-06	2001-10-05	Aliphatische stickstoffhaltige fünfgliedrige ringverbindungen

Country Status (20)

Country	Link
US (5)	US6849622B2 (de)
EP (2)	EP1325910B1 (de)
KR (2)	KR100555014B1 (de)
CN (2)	CN1280269C (de)
AT (2)	ATE407924T1 (de)
AU (4)	AU9419601A (de)
BR (1)	BR0114436A (de)
CA (2)	CA2424600C (de)
DE (2)	DE60135764D1 (de)
DK (2)	DK1323710T3 (de)
ES (2)	ES2312471T3 (de)
HU (1)	HUP0303391A3 (de)
IL (2)	IL154893A0 (de)
MX (2)	MXPA03003007A (de)
NO (1)	NO324519B1 (de)
NZ (2)	NZ524974A (de)
PL (1)	PL362545A1 (de)
PT (2)	PT1325910E (de)
TW (1)	TWI290919B (de)
WO (2)	WO2002030890A1 (de)

Families Citing this family (121)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10123163A1 (de) *	2001-05-09	2003-01-16	Gruenenthal Gmbh	Substituierte Cyclohexan-1,4-diaminderivate
EP1399420B1 (de)	2001-06-27	2007-12-05	SmithKline Beecham Corporation	Pyrrolidine als dipeptidyl peptidase inhibitoren
WO2003002531A2 (en)	2001-06-27	2003-01-09	Smithkline Beecham Corporation	Fluoropyrrolidines as dipeptidyl peptidase inhibitors
JP4357293B2 (ja)	2001-06-27	2009-11-04	スミスクラインビーチャムコーポレーション	ジペプチジルペプチダーゼ阻害剤としてのフルオロピロリジン類
US6861440B2 (en)	2001-10-26	2005-03-01	Hoffmann-La Roche Inc.	DPP IV inhibitors
EP1338595B1 (de)	2002-02-25	2006-05-03	Eisai Co., Ltd.	Xanthin-Derivate als DPP-IV-Inhibitoren
ATE349435T1 (de) *	2002-02-28	2007-01-15	Prosidion Ltd	Dpiv-inhibitoren auf glutaminbasis
HUP0200849A2 (hu)	2002-03-06	2004-08-30	Sanofi-Synthelabo	N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
DE10213051B4 (de) *	2002-03-23	2013-03-07	Grünenthal GmbH	Substituierte 4-Aminocyclohexanole
HUP0202001A2 (hu) *	2002-06-14	2005-08-29	Sanofi-Aventis	DDP-IV gátló hatású azabiciklooktán- és nonánszármazékok
WO2004007446A1 (ja) *	2002-07-10	2004-01-22	Yamanouchi Pharmaceutical Co., Ltd.	新規なアゼチジン誘導体又はその塩
TW200401635A (en)	2002-07-23	2004-02-01	Yamanouchi Pharma Co Ltd	2-Cyano-4-fluoropyrrolidine derivative or salt thereof
US7262207B2 (en)	2002-09-19	2007-08-28	Abbott Laboratories	Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
US7238724B2 (en)	2002-09-19	2007-07-03	Abbott Laboratories	Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
KR20050059294A (ko) *	2002-10-24	2005-06-17	스테릭스 리미티드	11-베타-하이드록시 스테로이드 데하이드로게나제 형태 1및 형태 2의 억제제
GB0224830D0 (en)	2002-10-24	2002-12-04	Sterix Ltd	Compound
DE10252666A1 (de)	2002-11-11	2004-08-05	Grünenthal GmbH	N-Piperidyl-cyclohexan-Derivate
US7550590B2 (en) *	2003-03-25	2009-06-23	Takeda Pharmaceutical Company Limited	Dipeptidyl peptidase inhibitors
US20050197350A1 (en) *	2003-03-31	2005-09-08	Taisho Pharmaceutical Co., Ltd.	Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof
CN101475528A (zh) *	2003-03-31	2009-07-08	大正制药株式会社	新的喹啉、四氢喹唑啉和嘧啶衍生物以及与其应用有关的治疗方法
US20090137658A1 (en) *	2003-05-06	2009-05-28	Tanabe Seiyaku Co.,Ltd.	Benzenesulfonic acid salt compounds
GB0310593D0 (en) *	2003-05-08	2003-06-11	Leuven K U Res & Dev	Peptidic prodrugs
WO2004103993A1 (en)	2003-05-14	2004-12-02	Syrrx, Inc.	Dipeptidyl peptidase inhibitors
EP1638968B1 (de)	2003-06-20	2009-07-29	F.Hoffmann-La Roche Ag	Hexahydropyridoisochinoline als dpp-iv-inhibitoren
ES2355105T3 (es)	2003-06-20	2011-03-22	F. Hoffmann-La Roche Ag	Pirido(2,1-a)isoquinolina como inhibidores de la dpp-iv.
US7169926B1 (en)	2003-08-13	2007-01-30	Takeda Pharmaceutical Company Limited	Dipeptidyl peptidase inhibitors
US7678909B1 (en)	2003-08-13	2010-03-16	Takeda Pharmaceutical Company Limited	Dipeptidyl peptidase inhibitors
WO2005016911A1 (en) *	2003-08-13	2005-02-24	Takeda Pharmaceutical Company Limited	4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors
HU227684B1 (en)	2003-08-29	2011-11-28	Sanofi Aventis	Adamantane and azabicyclo-octane and nonane derivatives and their use as dpp-iv inhibitors
US7205409B2 (en)	2003-09-04	2007-04-17	Abbott Laboratories	Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
EP1699777B1 (de) *	2003-09-08	2012-12-12	Takeda Pharmaceutical Company Limited	Dipeptidylpeptidase-hemmer
EP1697342A2 (de) *	2003-09-08	2006-09-06	Takeda Pharmaceutical Company Limited	Dipeptidyl peptidase inhibitoren
US7291744B2 (en)	2003-11-13	2007-11-06	Bristol-Myers Squibb Company	N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity
KR20170104639A (ko)	2003-11-17	2017-09-15	노파르티스 아게	디펩티딜 펩티다제 ⅳ 억제제의 용도
KR101146849B1 (ko)	2003-12-11	2012-05-16	미쓰비시 타나베 파마 코퍼레이션	α-아미노산 유도체 및 그 의약 용도
EP1697358A1 (de) *	2003-12-19	2006-09-06	Altana Pharma AG	Zwischenprodukte für die darstellung tricyclischer dihydropyranoimidazopyridinderivate
JP5122144B2 (ja)	2004-01-20	2013-01-16	ノバルティスアーゲー	直接圧縮製剤および方法
WO2005075421A1 (ja) *	2004-02-05	2005-08-18	Kyorin Pharmaceutical Co., Ltd.	ビシクロエステル誘導体
EA009902B1 (ru)	2004-02-13	2008-04-28	УОРНЕР-ЛАМБЕРТ КОМПАНИ Эл-Эл-Си	Модуляторы рецепторов андрогенов
KR20060129021A (ko) *	2004-02-18	2006-12-14	교린 세이야꾸 가부시키 가이샤	비시클로아미드 유도체
EP1719757B1 (de) *	2004-02-27	2013-10-09	Kyorin Pharmaceutical Co., Ltd.	Bicycloderivate
US7348346B2 (en)	2004-03-08	2008-03-25	Abbott Laboratories	Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
US7732446B1 (en)	2004-03-11	2010-06-08	Takeda Pharmaceutical Company Limited	Dipeptidyl peptidase inhibitors
UA85871C2 (uk) *	2004-03-15	2009-03-10	Такеда Фармасьютікал Компані Лімітед	Інгібітори дипептидилпептидази
US20090036448A1 (en) *	2004-03-30	2009-02-05	Taisho Pharmecutical Co., Ltd.	Pyrimidine derivatives and methods of treatment related to the use thereof
EP1737813A1 (de)	2004-04-13	2007-01-03	Warner-Lambert Company LLC	Androgenmodulatoren
EP1740533A1 (de)	2004-04-22	2007-01-10	Warner-Lambert Company LLC	Androgenmodulatoren
TW200604167A (en) *	2004-04-27	2006-02-01	Astellas Pharma Inc	Pyrrolidine derivatives
DE102004023632A1 (de) *	2004-05-10	2005-12-08	Grünenthal GmbH	Substituierte Cyclohexylcarbonsäure-Derivate
DE102004023507A1 (de)	2004-05-10	2005-12-01	Grünenthal GmbH	Substituierte Cyclohexylessigsäure-Derivate
DE102004023635A1 (de)	2004-05-10	2006-04-13	Grünenthal GmbH	Heteroarylsubstituierte Cyclohexyl-1,4-diamin-Derivate
US7687638B2 (en) *	2004-06-04	2010-03-30	Takeda San Diego, Inc.	Dipeptidyl peptidase inhibitors
JP4874965B2 (ja)	2004-07-08	2012-02-15	ワーナー−ランバートカンパニーリミテッドライアビリティーカンパニー	アンドロゲン調節剤
WO2006019965A2 (en)	2004-07-16	2006-02-23	Takeda San Diego, Inc.	Dipeptidyl peptidase inhibitors
WO2006012441A1 (en) *	2004-07-23	2006-02-02	Susan Marie Royalty	Peptidase inhibitors
CN101087756B (zh)	2004-07-23	2011-04-06	纽阿达有限责任公司	肽酶抑制剂
WO2006011035A1 (en) *	2004-07-23	2006-02-02	Glenmark Pharmaceuticals Ltd.	Novel dipeptidyl peptidase iv inhibitors; process for their preparation and compositions containing them
JP2008514546A (ja) *	2004-09-30	2008-05-08	大正製薬株式会社	ピリジン誘導体及びその使用に関連する治療法
EP1799639B1 (de)	2004-10-12	2013-09-04	Glenmark Pharmaceuticals S.A.	Neue dipeptidylpeptidase-iv-inhibitoren, pharmazeutische zusammensetzungen, die diese enthalten, und verfahren zu deren herstellung
CN101087757B (zh) *	2004-10-12	2013-01-02	格兰马克药品股份有限公司	二肽基肽酶ⅳ抑制剂、含有它们的药用组合物及其制备方法
EP2805953B1 (de) *	2004-12-21	2016-03-09	Takeda Pharmaceutical Company Limited	Dipeptidyl-Peptidase-Hemmer
DOP2006000008A (es)	2005-01-10	2006-08-31	Arena Pharm Inc	Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
EP2527337A1 (de) *	2005-04-14	2012-11-28	Bristol-Myers Squibb Company	Hemmer des 11-Beta-Hydroxysteroid-Dehydrogenase-1-Enzyms
WO2006116157A2 (en) *	2005-04-22	2006-11-02	Alantos Pharmaceuticals Holding, Inc.	Dipeptidyl peptidase-iv inhibitors
TW200724139A (en)	2005-05-05	2007-07-01	Warner Lambert Co	Androgen modulators
US7521557B2 (en)	2005-05-20	2009-04-21	Bristol-Myers Squibb Company	Pyrrolopyridine-based inhibitors of dipeptidyl peptidase IV and methods
WO2006129271A2 (en) *	2005-05-31	2006-12-07	Koninklijke Philips Electronics N.V.	Portable storage media, host device and method of accessing the content of the portable storage media by the host device
ATE550031T1 (de)	2005-06-06	2012-04-15	Univ Georgetown	Zusammensetzungen und verfahren für die lipomodellierung
MY152185A (en)	2005-06-10	2014-08-29	Novartis Ag	Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation
EP1760076A1 (de)	2005-09-02	2007-03-07	Ferring B.V.	FAP Inhibitoren
EP1942898B2 (de)	2005-09-14	2014-05-14	Takeda Pharmaceutical Company Limited	Dipeptidyl-peptidase-hemmer zur behandlung von diabetes
CN102935081B (zh) *	2005-09-14	2015-03-04	武田药品工业株式会社	用于治疗糖尿病的二肽基肽酶抑制剂
WO2007035629A2 (en)	2005-09-16	2007-03-29	Takeda Pharmaceutical Company Limited	Process for the preparation of pyrimidinedione derivatives
TW200745080A (en) *	2005-09-16	2007-12-16	Takeda Pharmaceuticals Co	Polymorphs of tartrate salt of 2-[2-(3-(R)-amino-piperidin-1-yl)-5-fluoro-6-oxo-6H-pyrimidin-1-ylmethyl]-benzonitrile and methods of use therefor
TW200745079A (en) *	2005-09-16	2007-12-16	Takeda Pharmaceuticals Co	Polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor
GB0526291D0 (en)	2005-12-23	2006-02-01	Prosidion Ltd	Therapeutic method
AU2007224066B2 (en) *	2006-03-08	2011-10-27	Kyorin Pharmaceutical Co., Ltd.	Method for producing aminoacetylpyrrolidinecarbonitrile derivative and production intermediate thereof
JP2009531456A (ja) *	2006-03-28	2009-09-03	武田薬品工業株式会社	（ｒ）−３−アミノピペリジン二塩酸塩の調製
WO2007112347A1 (en)	2006-03-28	2007-10-04	Takeda Pharmaceutical Company Limited	Dipeptidyl peptidase inhibitors
SI1971862T1 (sl)	2006-04-11	2011-02-28	Arena Pharm Inc	Postopki uporabe GPR119 receptorja za identificiranje spojin, uporabnih za povečanje kostne mase pri posamezniku
PE20071221A1 (es) *	2006-04-11	2007-12-14	Arena Pharm Inc	Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
WO2007148185A2 (en) *	2006-06-21	2007-12-27	Pfizer Products Inc.	Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors
US8324383B2 (en)	2006-09-13	2012-12-04	Takeda Pharmaceutical Company Limited	Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
TW200838536A (en) *	2006-11-29	2008-10-01	Takeda Pharmaceutical	Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
JP2010120851A (ja) *	2007-02-09	2010-06-03	Kyorin Pharmaceut Co Ltd	二量化シクロ誘導体
US8093236B2 (en)	2007-03-13	2012-01-10	Takeda Pharmaceuticals Company Limited	Weekly administration of dipeptidyl peptidase inhibitors
WO2008114857A1 (ja) *	2007-03-22	2008-09-25	Kyorin Pharmaceutical Co., Ltd.	アミノアセチルピロリジンカルボニトリル誘導体の製造方法
KR20120030570A (ko) *	2007-04-03	2012-03-28	미쓰비시 타나베 파마 코퍼레이션	디펩티딜 펩티다아제 4 저해 화합물과 감미료와의 병용
WO2009037719A1 (en) *	2007-09-21	2009-03-26	Lupin Limited	Novel compounds as dipeptidyl peptidase iv (dpp iv) inhibitors
WO2009116067A2 (en) *	2008-01-10	2009-09-24	Sun Pharma Advanced Research Company Limited	Novel derivatives of acyl cyanopyrrolidines
CL2008003653A1 (es) *	2008-01-17	2010-03-05	Mitsubishi Tanabe Pharma Corp	Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica.
US8278313B2 (en)	2008-03-11	2012-10-02	Abbott Laboratories	Macrocyclic spiro pyrimidine derivatives
US8436005B2 (en)	2008-04-03	2013-05-07	Abbott Laboratories	Macrocyclic pyrimidine derivatives
EP2108960A1 (de) *	2008-04-07	2009-10-14	Arena Pharmaceuticals, Inc.	Verfahren zur Verwendung eines A G Protein-gekoppelten Rezeptors zur Identifikation von Peptid YY (PYY) Sekretagoga und nützliche Verbindungen zur Behandlung von durch (PYY) Sekretagoga modulierten Zuständen und nützliche Verbindungen zur Behandlung von Zuständen durch PYY
CA2732984A1 (en) *	2008-08-07	2010-02-11	Kyorin Pharmaceutical Co., Ltd.	Process for production of bicyclo[2.2.2]octylamine derivative
US20110152342A1 (en) *	2008-08-14	2011-06-23	Hiroshi Uchida	Stabilized pharmaceutical composition
WO2010039124A1 (en) *	2008-09-30	2010-04-08	Mitsubishi Tanabe Pharma Corporation	Benzenesulfonic acid salt compounds
US7965235B2 (en) *	2009-02-24	2011-06-21	Raytheon Company	Multi-channel thinned TR module architecture
US7876263B2 (en) *	2009-02-24	2011-01-25	Raytheon Company	Asymmetrically thinned active array TR module and antenna architecture
GB2483614B (en)	2009-06-18	2014-12-03	Lupin Ltd	2-Amino-2- [8-(dimethyl carbamoyl)- 8-aza- bicyclo [3.2.1] oct-3-yl]-exo- ethanoyl derivatives as potent dpp-iv inhibitors
AR077642A1 (es)	2009-07-09	2011-09-14	Arena Pharm Inc	Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo
US20130023494A1 (en)	2010-04-06	2013-01-24	Arena Pharmaceuticals, Inc.	Modulators of the gpr119 receptor and the treatment of disorders related thereto
MX2013003184A (es)	2010-09-22	2013-06-07	Arena Pharm Inc	Moduladores del receptor gpr119 y el tratamiento de transtornos relacionados con el mismo.
US20140018371A1 (en)	2011-04-01	2014-01-16	Arena Pharmaceuticals, Inc.	Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
WO2012145361A1 (en)	2011-04-19	2012-10-26	Arena Pharmaceuticals, Inc.	Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012145604A1 (en)	2011-04-22	2012-10-26	Arena Pharmaceuticals, Inc.	Modulators of the gpr119 receptor and the treatment of disorders related thereto
US20140038889A1 (en)	2011-04-22	2014-02-06	Arena Pharmaceuticals, Inc.	Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
WO2012170702A1 (en)	2011-06-08	2012-12-13	Arena Pharmaceuticals, Inc.	Modulators of the gpr119 receptor and the treatment of disorders related thereto
EP2729468A4 (de) *	2011-07-05	2015-03-18	Merck Sharp & Dohme	Tricyclische heterozyklen als dipeptidylpeptidase-iv-hemmer
WO2013055910A1 (en)	2011-10-12	2013-04-18	Arena Pharmaceuticals, Inc.	Modulators of the gpr119 receptor and the treatment of disorders related thereto
CN102875558A (zh) *	2012-11-05	2013-01-16	贵州大学	2-氯-4-取代-8-硝基苯并呋喃[3,2-d]嘧啶类化合物及其制备方法和用途
WO2014074668A1 (en)	2012-11-08	2014-05-15	Arena Pharmaceuticals, Inc.	Modulators of gpr119 and the treatment of disorders related thereto
MY176401A (en)	2014-04-24	2020-08-05	Mitsubishi Tanabe Pharma Corp	Novel disubstituted 1,2,4-triazine compound
BR112017019170A2 (pt)	2015-03-09	2018-07-10	Intekrin Therapeutics, Inc.	métodos para o tratamento de doença do fígado gorduroso não alcoólico e / ou lipodistrofia
KR20200036808A (ko)	2017-04-03	2020-04-07	코히러스 바이오사이언시스, 인크.	진행성 핵상 마비 치료를 위한 PPARγ 작용제
WO2019154859A1 (en) *	2018-02-06	2019-08-15	Universität Heidelberg	Fap inhibitor
CN108218865B (zh) *	2018-03-31	2020-06-26	济南市儿童医院	一种酰胺类衍生物及其在心脑血管方面的应用
CN108456207B (zh) *	2018-03-31	2020-11-20	浙江药苑生物科技有限公司	一种酰胺类衍生物及其在心脑血管方面的应用
WO2020028482A1 (en)	2018-07-31	2020-02-06	The Trustees Of The University Of Pennsylvania	Small molecules that sensitize hiv-1 infected cells to antibody dependent cellular cytotoxicity
CN116650495B (zh) *	2021-12-10	2024-04-19	中南大学湘雅医院	芳香族化合物作为神经丛素蛋白-b2的激活剂以及在制备治疗骨质疏松症药物中的应用
WO2023233024A1 (en)	2022-06-03	2023-12-07	Universiteit Antwerpen	Dpp9 binding compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6512481B1 (en) *	1996-10-10	2003-01-28	Teratech Corporation	Communication system using geographic position data
TW492957B (en)	1996-11-07	2002-07-01	Novartis Ag	N-substituted 2-cyanopyrrolidnes
US6011155A (en) *	1996-11-07	2000-01-04	Novartis Ag	N-(substituted glycyl)-2-cyanopyrrolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
US6316612B1 (en) *	1997-08-22	2001-11-13	Ribozyme Pharmaceuticals, Inc.	Xylofuranosly-containing nucleoside phosphoramidites and polynucleotides
US6484015B1 (en) *	1997-10-27	2002-11-19	Lucent Technologies Inc.	Portable telephone antenna
CO5150173A1 (es)	1998-12-10	2002-04-29	Novartis Ag	Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv
US6107317A (en)	1999-06-24	2000-08-22	Novartis Ag	N-(substituted glycyl)-thiazolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
US6110949A (en)	1999-06-24	2000-08-29	Novartis Ag	N-(substituted glycyl)-4-cyanothiazolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
JP3551122B2 (ja) *	2000-04-07	2004-08-04	日本電気株式会社	携帯電話装置
TW583185B (en) *	2000-06-13	2004-04-11	Novartis Ag	N-(substituted glycyl)-2-cyanopyrrolidines and pharmaceutical composition for inhibiting dipeptidyl peptidase-IV (DPP-IV) or for the prevention or treatment of diseases or conditions associated with elevated levels of DPP-IV comprising the same
US6432969B1 (en)	2000-06-13	2002-08-13	Novartis Ag	N-(substituted glycyl)-2 cyanopyrrolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
US20040180925A1 (en)	2000-12-27	2004-09-16	Kenji Matsuno	Dipeptidylpeptidase-IV inhibitor

2001
- 2001-10-05 AT AT01974716T patent/ATE407924T1/de not_active IP Right Cessation
- 2001-10-05 NZ NZ524974A patent/NZ524974A/en unknown
- 2001-10-05 PT PT01974717T patent/PT1325910E/pt unknown
- 2001-10-05 PL PL01362545A patent/PL362545A1/xx not_active Application Discontinuation
- 2001-10-05 WO PCT/JP2001/008802 patent/WO2002030890A1/ja active IP Right Grant
- 2001-10-05 DK DK01974716T patent/DK1323710T3/da active
- 2001-10-05 US US10/398,486 patent/US6849622B2/en not_active Expired - Fee Related
- 2001-10-05 IL IL15489301A patent/IL154893A0/xx active IP Right Grant
- 2001-10-05 HU HU0303391A patent/HUP0303391A3/hu unknown
- 2001-10-05 TW TWNITROGEN-A patent/TWI290919B/zh not_active IP Right Cessation
- 2001-10-05 WO PCT/JP2001/008803 patent/WO2002030891A1/ja active IP Right Grant
- 2001-10-05 DE DE60135764T patent/DE60135764D1/de not_active Expired - Lifetime
- 2001-10-05 DE DE60135862T patent/DE60135862D1/de not_active Expired - Lifetime
- 2001-10-05 AT AT01974717T patent/ATE408597T1/de not_active IP Right Cessation
- 2001-10-05 DK DK01974717T patent/DK1325910T3/da active
- 2001-10-05 KR KR1020037004824A patent/KR100555014B1/ko not_active Expired - Fee Related
- 2001-10-05 MX MXPA03003007A patent/MXPA03003007A/es active IP Right Grant
- 2001-10-05 AU AU9419601A patent/AU9419601A/xx active Pending
- 2001-10-05 BR BR0114436-7A patent/BR0114436A/pt not_active IP Right Cessation
- 2001-10-05 NZ NZ525630A patent/NZ525630A/en unknown
- 2001-10-05 AU AU2001294196A patent/AU2001294196B2/en not_active Ceased
- 2001-10-05 ES ES01974716T patent/ES2312471T3/es not_active Expired - Lifetime
- 2001-10-05 CN CNB018169570A patent/CN1280269C/zh not_active Expired - Fee Related
- 2001-10-05 ES ES01974717T patent/ES2312472T3/es not_active Expired - Lifetime
- 2001-10-05 CN CNB018166741A patent/CN1257891C/zh not_active Expired - Fee Related
- 2001-10-05 AU AU2001294197A patent/AU2001294197C1/en not_active Ceased
- 2001-10-05 EP EP01974717A patent/EP1325910B1/de not_active Expired - Lifetime
- 2001-10-05 CA CA002424600A patent/CA2424600C/en not_active Expired - Fee Related
- 2001-10-05 CA CA002424964A patent/CA2424964C/en not_active Expired - Fee Related
- 2001-10-05 PT PT01974716T patent/PT1323710E/pt unknown
- 2001-10-05 AU AU9419701A patent/AU9419701A/xx active Pending
- 2001-10-05 EP EP01974716A patent/EP1323710B1/de not_active Expired - Lifetime
- 2001-10-05 KR KR10-2003-7004829A patent/KR100526091B1/ko not_active Expired - Fee Related
- 2001-10-05 US US10/398,485 patent/US7138397B2/en not_active Expired - Fee Related
- 2001-10-05 MX MXPA03003006A patent/MXPA03003006A/es active IP Right Grant
2003
- 2003-03-12 IL IL154893A patent/IL154893A/en not_active IP Right Cessation
- 2003-04-02 NO NO20031490A patent/NO324519B1/no not_active IP Right Cessation
2004
- 2004-06-22 US US10/872,442 patent/US7160877B2/en not_active Expired - Fee Related
2006
- 2006-06-15 US US11/452,923 patent/US7332487B2/en not_active Expired - Fee Related
2007
- 2007-12-07 US US12/000,024 patent/US7666869B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ATE407924T1 (de)	2008-09-15
WO2002030890A8 (fr)	2002-05-16
US20050054678A1 (en)	2005-03-10
CN1468216A (zh)	2004-01-14
EP1323710B1 (de)	2008-09-10
US20080153821A1 (en)	2008-06-26
CA2424964C (en)	2007-12-04
TWI290919B (en)	2007-12-11
IL154893A (en)	2008-04-13
NZ525630A (en)	2004-10-29
AU2001294197C1 (en)	2005-05-19
DK1325910T3 (da)	2008-11-10
US20040229926A1 (en)	2004-11-18
HUP0303391A2 (hu)	2004-03-01
US20060241146A1 (en)	2006-10-26
US6849622B2 (en)	2005-02-01
US7160877B2 (en)	2007-01-09
US7332487B2 (en)	2008-02-19
NO324519B1 (no)	2007-11-12
WO2002030890A1 (fr)	2002-04-18
EP1325910B1 (de)	2008-09-17
CA2424964A1 (en)	2002-04-18
EP1323710A1 (de)	2003-07-02
WO2002030891A1 (fr)	2002-04-18
NO20031490L (no)	2003-06-02
WO2002030891A8 (fr)	2002-05-16
NO20031490D0 (no)	2003-04-02
CN1280269C (zh)	2006-10-18
AU2001294196B2 (en)	2005-11-17
AU9419601A (en)	2002-04-22
CN1257891C (zh)	2006-05-31
EP1325910A1 (de)	2003-07-09
MXPA03003006A (es)	2003-07-14
BR0114436A (pt)	2003-07-01
EP1323710A4 (de)	2005-05-18
KR100526091B1 (ko)	2005-11-08
MXPA03003007A (es)	2003-07-14
KR100555014B1 (ko)	2006-03-03
US7138397B2 (en)	2006-11-21
DK1323710T3 (da)	2008-12-01
CA2424600A1 (en)	2003-04-02
KR20030041149A (ko)	2003-05-23
EP1325910A4 (de)	2005-05-18
US7666869B2 (en)	2010-02-23
HK1055302A1 (en)	2004-01-02
HUP0303391A3 (en)	2004-04-28
AU9419701A (en)	2002-04-22
CN1468217A (zh)	2004-01-14
AU2001294197B2 (en)	2004-09-16
ES2312472T3 (es)	2009-03-01
PT1325910E (pt)	2008-10-27
PL362545A1 (en)	2004-11-02
PT1323710E (pt)	2008-11-25
HK1055301A1 (en)	2004-01-02
ES2312471T3 (es)	2009-03-01
CA2424600C (en)	2008-12-02
NZ524974A (en)	2005-10-28
IL154893A0 (en)	2003-10-31
ATE408597T1 (de)	2008-10-15
US20040063935A1 (en)	2004-04-01
KR20030041148A (ko)	2003-05-23
DE60135862D1 (de)	2008-10-30

Publication	Publication Date	Title
DE60135764D1 (de)	2008-10-23	Stickstoffhaltige, fünfgliedrige ringverbindungen
ATE267814T1 (de)	2004-06-15	Substituierte kondensierte heterocyclische verbindungen
DK0870765T3 (da)	2004-02-23	Aminothiazolderivat, lægemiddel indeholdende samme og mellemprodukt til fremstilling af forbindelsen
IL147651A0 (en)	2002-08-14	Isoxazoline derivative and herbicide containing the same as the active ingredient
ATE368655T1 (de)	2007-08-15	Stickstoffhaltige heterocyclische verbindung und arzneimittel davon
AU3417501A (en)	2001-09-12	Novel cyclic amide derivatives
ATE271045T1 (de)	2004-07-15	Sauerstoffhaltige heterocyclische verbindungen
WO2001010834A3 (en)	2001-06-28	Antibacterial agents
EP1156031A4 (de)	2004-09-15	Verbindungen, aus der verbindung hergestelltes polymer und das polymer enthaltende mischung
AU9025601A (en)	2002-04-02	Cephem compounds and esbl-detecting reagents containing the same
EP0552489A3 (de)	1994-02-16
EA200101050A1 (ru)	2002-04-25	Замещенные бензолактамные соединения
DE60221250D1 (de)	2007-08-30	Bis(5-aryl-2-pyridyl)derivate
TW200510300A (en)	2005-03-16	Amino alcohol compounds
EP1391450A4 (de)	2005-08-17	N-(heterocyclylmethyl)alkylamin derivate, verfahren zu deren herstellung und bakterizid

Legal Events

Date	Code	Title	Description
2009-10-01	8364	No opposition during term of opposition